FIELD: medicine. SUBSTANCE: composition has Enalapryl dose or its pharmaceutically permissible salt and different dose of Nitrenedipine or its pharmaceutically permissible salt. The composition is administered in single dose as galenic preparation. Method involves a) dissolving Enalapryl maleate in water with organic salt; b) mixing microionized Nitrenedipine with loosening fillers fraction, moistening agents, fragmental diluting agent, gluing agent and plastic diluting agent preliminarily sieved; c) granulating products homogenized at (b) stage with solution produced at (a); d) drying the granulated mass; e) introducing lubricating agent and the rest of the loosening fillers fraction and homogenizing the calibrated granulate; f) pressing the granulate. EFFECT: enhanced effectiveness of treatment; reduced risk of adverse side effects. 10 cl, 3 dwg, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USING HYALURONIDASE FOR PREVENTING OR TREATING ARTERIAL HYPERTENSION OR CARDIAC FAILURE | 2009 |
|
RU2508124C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| APPLICATION OF ORGANIC COMPOUNDS | 2005 |
|
RU2426532C2 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| COMBINED HYPOTENSIVE DRUG | 2010 |
|
RU2444371C1 |
| STABLE PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE ACTION | 2007 |
|
RU2341254C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING ARTERIAL HYPERTENSION | 2010 |
|
RU2448701C2 |
| HYPERTENSION TREATMENT IN WOMEN UNDERWENT HORMON REPLACEMENT THERAPY | 2003 |
|
RU2373940C2 |
| MEDICINAL AGENT FOR TREATMENT OF HYPERTENSION OR HIGH BLOOD PRESSURE | 2010 |
|
RU2539382C2 |
| RENIN INHIBITOR-CONTAINING SYNERGETIC COMPOSITIONS DESIGNATED FOR TREATMENT OF CARDIOVASCULAR DISEASE | 2001 |
|
RU2310443C2 |
